Literature DB >> 25926909

Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Mariana Horta1, Teresa Margarida Cunha2, Rita Canas Marques3, Ana Félix3.   

Abstract

Here we describe the case of a 19-year-old woman with a poorly differentiated ovarian Sertoli-Leydig cell tumor and an elevated serum alpha-fetoprotein level. The patient presented with diffuse abdominal pain and bloating. Physical examination, ultrasound, and magnetic resonance imaging revealed a right ovarian tumor that was histopathologically diagnosed as a poorly differentiated Sertoli-Leydig cell tumor with heterologous elements. Her alpha-fetoprotein serum level was undetectable after tumor resection. Sertoli-Leydig cell tumors are rare sex cord-stromal tumors that account for 0.5% of all ovarian neoplasms. Sertoli-Leydig cell tumors tend to be unilateral and occur in women under 30 years of age. Although they are the most common virilizing tumor of the ovary, about 60% are endocrine-inactive tumors. Elevated serum levels of alpha-fetoprotein are rarely associated with Sertoli-Leydig cell tumors, with only approximately 30 such cases previously reported in the literature. The differential diagnosis should include common alpha-fetoprotein-producing ovarian entities such as germ cell tumors, as well as other non-germ cell tumors that have been rarely reported to produce this tumor marker.

Entities:  

Keywords:  Alpha-fetoprotein; Magnetic resonance; Ovarian tumor; Sertoli-Leydig tumor; Sex cord-stromal tumor; Ultrasound

Mesh:

Substances:

Year:  2014        PMID: 25926909      PMCID: PMC4394981          DOI: 10.3941/jrcr.v8i11.2272

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  60 in total

1.  Sertoli Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report.

Authors:  Z N Singh; M K Singh; P Chopra
Journal:  J Obstet Gynaecol Res       Date:  1996-12       Impact factor: 1.730

2.  Ovarian Sertoli-Leydig cell tumor in a 9-month-old infant with special histologic pattern.

Authors:  Hong Shu; Xiang hong Yang; Ai Feng Gao
Journal:  Fetal Pediatr Pathol       Date:  2012-03-23       Impact factor: 0.958

3.  Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.

Authors:  Cristina Sigismondi; Angiolo Gadducci; Domenica Lorusso; Massimo Candiani; Enrico Breda; Francesco Raspagliesi; Gennaro Cormio; Marco Marinaccio; Giorgia Mangili
Journal:  Gynecol Oncol       Date:  2012-03-22       Impact factor: 5.482

Review 4.  CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.

Authors:  Seung Eun Jung; Jae Mun Lee; Sung Eun Rha; Jae Young Byun; Jung Im Jung; Seong Tai Hahn
Journal:  Radiographics       Date:  2002 Nov-Dec       Impact factor: 5.333

5.  Virilizing tumors of the ovary: imaging features.

Authors:  E K Outwater; B Marchetto; B J Wagner
Journal:  Ultrasound Obstet Gynecol       Date:  2000-05       Impact factor: 7.299

6.  Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.

Authors:  Rani Akhil Bhat; Yong Kuei Lim; Yin Nin Chia; Kwai Lam Yam
Journal:  J Obstet Gynaecol Res       Date:  2012-06-13       Impact factor: 1.730

7.  Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein. A case report.

Authors:  K Nomura; Y Miyasaka; M Murae; Y Terashima; S Aizawa
Journal:  Acta Pathol Jpn       Date:  1992-05

Review 8.  Sertoli cell tumor: a rare case in an elderly patient.

Authors:  M O Nicoletto; E Caltarossa; M Donach; G B Nardelli; A Parenti; A Ambrosini
Journal:  Eur J Gynaecol Oncol       Date:  2006       Impact factor: 0.196

Review 9.  Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

10.  Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.

Authors:  R H Young; A R Perez-Atayde; R E Scully
Journal:  Am J Surg Pathol       Date:  1984-09       Impact factor: 6.394

View more
  2 in total

1.  Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature.

Authors:  Trisha Plastini; Arthur Staddon
Journal:  Case Rep Med       Date:  2017-07-02

2.  Sertoli-Leydig cell tumors of ovary: A case series.

Authors:  Qiong Xu; Yu Zou; Xiao Fei Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.